Tech Company Financing Transactions
Regado Biosciences Funding Round
Regado Biosciences, operating out of San Francisco, raised $10.3 million in funding from Domain Associates and private investors.
Transaction Overview
Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$10,311,000
Round
Undisclosed
Investors
Domain Associates (Dennis Podlesak)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
701 Gateway Blvd. 300
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Regado (NASDAQ: RGDO) is a spin-out of the Department of Surgery at Duke University Medical Center. Regado's technology enables the rational design of drug-antidote pairs against any target accessible to the bloodstream.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurent Fischer
Chief Financial Officer
Christopher Peetz
Chief Medical Officer
Eric Lefebvre
Chief Operating Officer
Helen Jenkins
Browse more venture capital transactions:
Prev: 3/31/2013: OptiScan Biomedical venture capital transaction
Next: 3/31/2013: Medicalis venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs